{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:33:57Z","timestamp":1772764437172,"version":"3.50.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1097\/iae.0b013e3181884ff4","type":"journal-article","created":{"date-parts":[[2008,10,29]],"date-time":"2008-10-29T07:16:49Z","timestamp":1225264609000},"page":"1387-1394","source":"Crossref","is-referenced-by-count":49,"title":["PRIMARY INTRAVITREAL BEVACIZUMAB FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION"],"prefix":"10.1097","volume":"28","author":[{"given":"J FERNANDO","family":"AREVALO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JANS","family":"FROMOW-GUERRA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUAN G.","family":"SANCHEZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAURICIO","family":"MAIA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARIA H.","family":"BERROCAL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LIHTEH","family":"WU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARIO J.","family":"SARAVIA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ROGERIO A.","family":"COSTA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJM199407143310207","article-title":"Diseases of the retina.","volume":"331","author":"D\u2019Amico","year":"1994","journal-title":"N Engl J Med"},{"key":"R2-2-20210130","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archopht.121.11.1621","article-title":"Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11.","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R3-2-20210130","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ajo.2003.11.069","article-title":"The epidemiology of age-related macular degeneration.","volume":"137","author":"Klein","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R4-2-20210130","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archopht.122.4.477","article-title":"Causes and prevalence of visual impairment among adults in the United States.","volume":"122","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R5-2-20210130","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.122.4.564","article-title":"Prevalence of age related macular degeneration in the United States.","volume":"122","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R6-2-20210130","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/archopht.1984.01040031330019","article-title":"Age-related macular degeneration and blindness due to neovascular maculopathy.","volume":"102","author":"Ferris","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"R7-2-20210130","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress.","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr Rev"},{"key":"R8-2-20210130","first-page":"574","article-title":"Vascular endothelial growth factor\/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.","volume":"145","author":"Miller","year":"1994","journal-title":"Am J Pathol"},{"key":"R9-2-20210130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archopht.1996.01100130062010","article-title":"Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.","volume":"114","author":"Adamis","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"R10-2-20210130","first-page":"S501","article-title":"Vascular endothelial growth factor expression is correlated with choroidal neovascularization in a monkey model.","volume":"38","author":"Husain","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R11-2-20210130","first-page":"3178","article-title":"Growth factor localization in choroidal neovascular membranes of age-related macular degeneration.","volume":"35","author":"Amin","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R12-2-20210130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bjo.81.2.154","article-title":"Increased expression of angiogenic growth factors in age related maculopathy.","volume":"81","author":"Kliffen","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"R13-2-20210130","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ajo.2003.11.026","article-title":"Pathogenesis of lesions in late age-related macular disease.","volume":"137","author":"Holz","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R14-2-20210130","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archopht.120.3.338","article-title":"Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.","volume":"120","author":"Krzystolik","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"R15-2-20210130","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration.","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N Engl J Med"},{"key":"R16-2-20210130","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00006982-200510000-00001","article-title":"Enhanced efficacy associated with early treatment of neovascular age-related macular degeneration with pegaptanib sodium: an exploratory analysis.","volume":"25","year":"2005","journal-title":"Retina"},{"key":"R17-2-20210130","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/jama.293.12.1509","article-title":"Inhibitors of ocular neovascularization: promises and potential problems.","volume":"293","author":"van Wijngaarden","year":"2005","journal-title":"JAMA"},{"key":"R18-2-20210130","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer.","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"R19-2-20210130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00006982-200603000-00004","article-title":"Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage.","volume":"26","author":"Spaide","year":"2006","journal-title":"Retina"},{"key":"R20-2-20210130","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ophtha.2005.02.007","article-title":"Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study.","volume":"112","author":"Michels","year":"2005","journal-title":"Ophthalmology"},{"key":"R21-2-20210130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","article-title":"Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"R22-2-20210130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00006982-200603000-00005","article-title":"Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.","volume":"26","author":"Iturralde","year":"2006","journal-title":"Retina"},{"key":"R23-2-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2006.02.037","article-title":"Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration.","volume":"142","author":"Bashshur","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R24-2-20210130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00417-006-0412-5","article-title":"Intravitreal bevacizumab for exudative age-related macular degeneration after multiple treatments.","volume":"245","author":"Aggio","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R25-2-20210130","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/01.iae.0000244380.34082.67","article-title":"Visual improvement following intravitreal bevacizumab (Avastin) in exudative age-related macular degeneration.","volume":"26","author":"Yoganathan","year":"2006","journal-title":"Retina"},{"key":"R26-2-20210130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00006982-200603000-00003","article-title":"Electrophysiologic findings after intravitreal bevacizumab (Avastin) treatment.","volume":"26","author":"Maturi","year":"2006","journal-title":"Retina"},{"key":"R27-2-20210130","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00006982-200603000-00002","article-title":"Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin).","volume":"26","author":"Shahar","year":"2006","journal-title":"Retina"},{"key":"R28-2-20210130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00006982-200603000-00001","article-title":"Testing intravitreal toxicity of bevacizumab (Avastin).","volume":"26","author":"Manzano","year":"2006","journal-title":"Retina"},{"key":"R29-2-20210130","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/01.iae.0000234629.22614.cd","article-title":"Case of anterior uveitis after intravitreal injection of bevacizumab.","volume":"26","author":"Pieramici","year":"2006","journal-title":"Retina"},{"key":"R30-2-20210130","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/bjo.2006.093732","article-title":"Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration.","volume":"90","author":"Meyer","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R31-2-20210130","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.ajo.2006.06.048","article-title":"Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration.","volume":"142","author":"Spandau","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R32-2-20210130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00417-007-0660-z","article-title":"Twelve month safety of intravitreal injections of bevacizumab (Avastin\u00ae): results of the Pan American Collaborative Retina Study Group (PACORES).","volume":"246","author":"Wu","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R33-2-20210130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3928\/1542-8877-20050701-14","article-title":"Optical coherence tomography findings after intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration.","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R34-2-20210130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.iae.0000238561.99283.0e","article-title":"Intravitreal bevacizumab treatment of choroidal neovascularization secondary to agerelated macular degeneration.","volume":"26","author":"Spaide","year":"2006","journal-title":"Retina"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006982-200811000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T02:17:19Z","timestamp":1618366639000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-200811000-00002"}},"subtitle":["Results of the Pan-American Collaborative Retina Study Group at 12 Months Follow-up"],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181884ff4","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}